Creative Biolabs is drawing attention to a set of research products and services aimed at improving functional evaluation and experimental control in two distinct but methodologically demanding fields: complement biology and droplet microfluidics. The announcement, made in Shirley, NY, on October 28, 2026, underscores the company's effort to provide researchers with tools that deliver more than a single endpoint and help address common challenges such as assay variability, limited functional readouts, and inconsistent droplet formation.
In complement-targeted drug research, binding data alone may offer limited insight into downstream biological effects. To support classical pathway studies, Creative Biolabs offers its CH50 functional test kit, a hemolysis-based assay designed to measure the functional activity of the classical complement pathway through antibody-sensitized red blood cell lysis. The kit is compatible with serum or plasma samples from multiple species, including humans, mice, and rats, and can be used in complement function studies as well as research involving complement inhibitors or activators. For programs requiring additional functional characterization, the company's hemolysis inhibition profiling service uses hemolytic readouts to assess changes in complement-mediated red blood cell lysis following inhibitor treatment. By examining concentration-dependent inhibition responses, the service can support inhibitor potency assessment, comparative activity profiling, and mechanism-of-action investigations. Depending on the research objectives, classical or alternative pathway assays may be incorporated to address pathway-specific questions.
Researchers using droplet microfluidics face a different but related challenge: generating droplets with suitable consistency for encapsulation, screening, and compartmentalized assay workflows. Creative Biolabs' flow focusing droplet generation chip uses a flow-focusing configuration in which interactions between a continuous phase and a dispersed phase promote droplet formation within microchannels. The PDMS-based chip is designed for water-in-oil and oil-in-water droplet generation and can also be applied to research involving single-cell encapsulation. Such microfluidic systems may help researchers establish more controlled experimental conditions while adapting droplet generation parameters to specific study requirements, with potential applications including sample compartmentalization, cell encapsulation, and the development of droplet-based screening workflows.
Although functional complement testing and droplet microfluidics address distinct experimental requirements, both reflect the importance of selecting appropriate research tools and measurable endpoints. By providing functional complement assay solutions alongside microfluidic research tools, Creative Biolabs aims to support researchers working to refine experimental workflows, broaden functional characterization, and select research formats suited to different biological questions. All referenced products and services are intended for research use only and are not for diagnostic or therapeutic use in humans. To explore Creative Biolabs' complement research products and services, researchers can visit https://www.creative-biolabs.com/complement-therapeutics/.
